| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 6 |
| 1 | ATEZOLIZUMAB | 3 |
| 2 | BEVACIZUMAB | 3 |
| 3 | LANSOPRAZOLE | 3 |
| 4 | CARVEDILOL | 2 |
| 5 | DAPAGLIFLOZIN | 2 |
| 6 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 |
| 7 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 |
| 8 | ADALIMUMAB | 1 |
| 9 | ASPIRIN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 2 | 0.0007 |
| 1 | SELUMETINIB | 1 | 0.0006 |
| 2 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 2 | 0.0006 |
| 3 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0003 |
| 4 | DUTASTERIDE | 1 | 0.0001 |
| 5 | EMPAGLIFLOZIN | 6 | 0.0001 |
| 6 | ATEZOLIZUMAB | 3 | 0.0001 |
| 7 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 8 | DAPAGLIFLOZIN | 2 | 0.0000 |
| 9 | VITAMIN E | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 10 | 0.0001 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 3 | alpha-Adrenergic Blocker [EPC] | 2 | 0.0000 |
| 4 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 5 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | beta-Adrenergic Blocker [EPC] | 2 | 0.0000 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 2 | 0.0000 |
| 8 | Proton Pump Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Vitamin C [EPC] | 1 | 0.0000 |